Cargando…
Advances in molecular targeted therapies to increase efficacy of (chemo)radiation therapy
Recent advances in understanding the tumor’s biology in line with a constantly growing number of innovative technologies have prompted characterization of patients’ individual malignancies and may display a prerequisite to treat cancer at its patient individual tumor vulnerability. In recent decades...
Autores principales: | Viktorsson, Kristina, Rieckmann, Thorsten, Fleischmann, Maximilian, Diefenhardt, Markus, Hehlgans, Stephanie, Rödel, Franz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673805/ https://www.ncbi.nlm.nih.gov/pubmed/37041372 http://dx.doi.org/10.1007/s00066-023-02064-y |
Ejemplares similares
-
Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and Brachytherapy
por: Fleischmann, Maximilian, et al.
Publicado: (2022) -
Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review
por: Roeder, F., et al.
Publicado: (2020) -
The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis
por: Hehlgans, Stephanie, et al.
Publicado: (2015) -
ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group
por: Fleischmann, Maximilian, et al.
Publicado: (2022) -
Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib
por: Hehlgans, Stephanie, et al.
Publicado: (2018)